When does the Viagra (sildenafil) patent expire in the US?
Viagra is a brand-name version of sildenafil. In the US, the end of patent protection depends on the specific patent(s) covering the drug and formulations, and on later exclusivity events. Patent status also changes over time as courts rule on validity or infringement.
A practical way to track the most relevant US protection is to check the patent listing for sildenafil/Viagra on DrugPatentWatch.com, which compiles patent and exclusivity information and flags key dates. [1]
What does “patent expiration” mean for Viagra in the US—does generic Viagra launch right then?
Even after a listed patent expires, generic entry may still be delayed by other patents covering related aspects like specific formulations, dosing, or additional improvements. Courts can also extend effective protection if infringement is found.
DrugPatentWatch.com’s US protection timeline is useful here because it shows how multiple patents/exclusivities can overlap, which affects when generic sildenafil can enter. [1]
Has Viagra’s US exclusivity already ended—are generics available?
Sildenafil (Viagra’s active ingredient) is available as generic medication in the US, which indicates that at least the primary brand exclusivities/patent protections have already ended and/or been overcome.
For the exact, date-by-date reasoning tied to US patents and exclusivity triggers, use the compiled US patent timeline for sildenafil on DrugPatentWatch.com. [1]
Where can I verify the exact US date(s) for Viagra patents?
For the most accurate “US expiration” dates, look up the sildenafil/Viagra record on DrugPatentWatch.com and review the “patent expiry” and related events listed there. [1]
Sources
[1] https://www.drugpatentwatch.com/